FLINN

Six Arizona Startups Driving Biosciences Forward in 2024

Retrieved on: 
Wednesday, April 3, 2024
Other Philanthropy, Other Science, Pharmaceutical, Oncology, Start-Up, Medical Devices, Infectious Diseases, Professional Services, Foundation, Genetics, Philanthropy, Science, Veterinary, Clinical Trials, FDA, General Health, Biotechnology, Surgery, Health, Entrepreneurship, AI, Quality of life, Surgeon, Dog, MMP7, Hepatology, Itch

Each startup will receive $30,000 in non-dilutive funding via the Arizona Bioindustry Association, the Flinn Foundation’s nonprofit partner.

Key Points: 
  • Each startup will receive $30,000 in non-dilutive funding via the Arizona Bioindustry Association, the Flinn Foundation’s nonprofit partner.
  • AZBio will also assist in developing a personalized learning plan and offer support services for the participants.
  • The product is a treatment for itching caused by canine atopic dermatitis with topical and oral administration.
  • This product will require a single blood draw, with results the same day, aiming to simplify and accelerate care while significantly reducing health care costs for children.

Flinn Foundation Names Leadership of Arizona’s Statewide Bioscience Committee

Retrieved on: 
Tuesday, February 27, 2024
Philanthropy, Health, Foundation, General Health, Research, Science, Biotechnology, Tubing (recreation), Public policy, Growth, Entrepreneurship, Rural health, Education, STEM, Roadmap, Arizona State Legislature, Public health, Associate, Arizona Center, Medical imaging, ASU, SPIE, University, Private sector, Ovarian cancer, Biomedical engineering, Policy, Biological engineering, National Advisory Council (India), Workforce, Committee, Management

The committee, administered by the Flinn Foundation, is the statewide leadership group responsible for overseeing Arizona’s Bioscience Roadmap, the long-term strategic plan to guide the growth and development of the state’s bioscience sector.

Key Points: 
  • The committee, administered by the Flinn Foundation, is the statewide leadership group responsible for overseeing Arizona’s Bioscience Roadmap, the long-term strategic plan to guide the growth and development of the state’s bioscience sector.
  • Barton, who became a committee member in 2013, will be in a committee leadership position for the first time.
  • Over the next 18 months, the committee’s guidance will be critical in the Flinn Foundation’s planned update to Arizona’s Bioscience Roadmap—the first since 2014.
  • Carter joins a distinguished group of community and bioscience leaders who have led the committee since its inception in 2002.

Flinn Foundation Adds Two Phoenix Business Leaders to Its Board of Directors

Retrieved on: 
Monday, February 12, 2024
Research, Philanthropy, Biotechnology, Health, General Health, Other Philanthropy, Foundation, Other Science, Science, Civic, Economic development, Multimedia, Journalism, Education, Culture, Arizona Center, Commerce, International Economic Development Council, Jews, Phoenix Art Museum, Artlink, Thunderbird, Goodman, Greater Phoenix Economic Council, Phoenix Symphony, Policy, Medicine, Quality of life, Entrepreneurship, Partnership, Management

Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors.

Key Points: 
  • Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors.
  • Goodman represents the third generation to lead the Goodmans family business, a furniture and office design company.
  • “Both Chris and Adam are dynamic, innovative leaders whose energy and expertise in economic development and business will be strong additions to the Flinn board of directors,” said Tammy McLeod, Ph.D., Flinn Foundation president and CEO.
  • The first meeting for Camacho and Goodman as members of the Flinn Foundation board of directors will be in March.

Dr. David Gullen to Hand Over Flinn Foundation Board Chair After More Than Two Decades of Service

Retrieved on: 
Thursday, March 30, 2023
Philanthropy, Health, Foundation, General Health, Research, Science, Civic, Reimann, University of Oxford, Duke University, Mayo Clinic, Translational Genomics Research Institute, Arizona Center, University, Internal medicine, Culture, Physician, American Board of Internal Medicine, Mayo Clinic College of Medicine and Science, PET, Multimedia, Arizona Public Service, Private practice, Medicine, Princeton University, American College of Physicians, American Board of Commissioners for Foreign Missions, Neuroscience, Entrepreneurship, Arizona State University, Medical Center, Washington University School of Medicine, Strong Memorial Hospital, Associate, Growth, Hospital, Regent, WebPT, American College, ST, Havasupai Tribe v. the Arizona Board of Regents, Psychiatry, Roadmap, Microbiology, Pension fund, Pharmaceutical industry, Management, Nursing, Phoenix

Dr. David Gullen, the longest-serving member of the Flinn Foundation board of directors, is stepping down as chair after 21 years of leading the philanthropic grantmaking organization.

Key Points: 
  • Dr. David Gullen, the longest-serving member of the Flinn Foundation board of directors, is stepping down as chair after 21 years of leading the philanthropic grantmaking organization.
  • View the full release here: https://www.businesswire.com/news/home/20230329006005/en/
    Dr. David Gullen served as chair of the Flinn Foundation board of directors from 2002 to March 2023.
  • Gullen, a physician who practiced internal medicine in the Phoenix area for nearly 35 years before retiring, joined the Flinn board in 1989 and was named chair in 2002.
  • The Flinn Scholars Program was a new initiative when Gullen first joined the board and continues today as the most prestigious college scholarship in Arizona.